Journal article · 2024 · Open access

Expansion of artemisinin partial resistance mutations and lack of histidine rich protein-2 and -3 deletions in Plasmodium falciparum infections from Rukara, Rwanda

Cecile Schreidah, David Giesbrecht, Pierre Gashema, Neeva Wernsman Young, Tharcisse Munyaneza, Claude Mambo Muvunyi, Kyaw L. Thwai, Jean-Baptiste Mazarati, Jeffrey A. Bailey, Jonathan J. Juliano, Corine Karema

Malaria Journal, 23(1), 150 · Published 16 May 2024 · DOI 10.1186/s12936-024-04981-4

Open full textCite this paper

In brief

“Expansion of artemisinin partial resistance mutations and lack of histidine rich protein-2 and -3 deletions in Plasmodium falciparum infections from Rukara, Rwanda” is a 2024 journal article by Cecile Schreidah and 10 co-authors, published in Malaria Journal. OpenAlex counts 27 citations as of 19 November 2026, which puts it in the top 4% of works published in 2024 by citations. It is open access under a CC BY licence: the full text is free to read at Malaria Journal.

Citations
27
Most cited in
2026 (13)
Field-weighted impact
7.29
References
44
Authors
11

Abstract

BACKGROUND: Emerging artemisinin partial resistance and diagnostic resistance are a threat to malaria control in Africa. Plasmodium falciparum kelch13 (k13) propeller-domain mutations that confer artemisinin partial resistance have emerged in Africa. k13-561H was initially described at a frequency of 7.4% from Masaka in 2014-2015, but not present in nearby Rukara. By 2018, 19.6% of isolates in Masaka and 22% of isolates in Rukara contained the mutation. Longitudinal monitoring is essential to inform control efforts. In Rukara, an assessment was conducted to evaluate recent k13-561H prevalence changes, as well as other key mutations. Prevalence of hrp2/3 deletions was also assessed. METHODS: Samples collected in Rukara in 2021 were genotyped for key artemisinin and partner drug resistance mutations using molecular inversion probe assays and for hrp2/3 deletions using qPCR. RESULTS: Clinically validated k13 artemisinin partial resistance mutations continue to increase in prevalence with the overall level of mutant infections reaching 32% in Rwanda. The increase appears to be due to the rapid emergence of k13-675V (6.4%, 6/94 infections), previously not observed, rather than continued expansion of 561H (23.5% 20/85). Mutations to partner drugs and other anti-malarials were variable, with high levels of multidrug resistance 1 (mdr1) N86 (95.5%) associated with lumefantrine decreased susceptibility and dihydrofolate reductase (dhfr) 164L (24.7%) associated with a high level of antifolate resistance, but low levels of amodiaquine resistance polymorphisms with chloroquine resistance transporter (crt) 76T: at 6.1% prevalence. No hrp2 or hrp3 gene deletions associated with diagnostic resistance were found. CONCLUSIONS: Increasing prevalence of artemisinin partial resistance due to k13-561H and the rapid expansion of k13-675V is concerning for the longevity of artemisinin effectiveness in the region. False negative RDT results do not appear to be an issue with no hrp2 or hpr3 deletions detected. Continued molecular surveillance in this region and surrounding areas is needed to follow artemisinin partial resistance and provide early detection of partner drug resistance, which would likely compromise control and increase malaria morbidity and mortality in East Africa.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Schreidah, C., Giesbrecht, D., Gashema, P., Young, N. W., Munyaneza, T., Muvunyi, C. M., Thwai, K. L., Mazarati, J.-B., Bailey, J. A., Juliano, J. J., & Karema, C. (2024). Expansion of artemisinin partial resistance mutations and lack of histidine rich protein-2 and -3 deletions in Plasmodium falciparum infections from Rukara, Rwanda. Malaria Journal, 23(1), 150. https://doi.org/10.1186/s12936-024-04981-4

MLA 9

Schreidah, Cecile, et al. “Expansion of artemisinin partial resistance mutations and lack of histidine rich protein-2 and -3 deletions in Plasmodium falciparum infections from Rukara, Rwanda.” Malaria Journal, vol. 23, no. 1, 2024, p. 150. https://doi.org/10.1186/s12936-024-04981-4.

Chicago

Schreidah, Cecile, David Giesbrecht, Pierre Gashema, Neeva Wernsman Young, Tharcisse Munyaneza, Claude Mambo Muvunyi, Kyaw L. Thwai, et al. 2024. “Expansion of artemisinin partial resistance mutations and lack of histidine rich protein-2 and -3 deletions in Plasmodium falciparum infections from Rukara, Rwanda.” Malaria Journal 23 (1): 150. https://doi.org/10.1186/s12936-024-04981-4.

Harvard

Schreidah, C. et al. (2024) ‘Expansion of artemisinin partial resistance mutations and lack of histidine rich protein-2 and -3 deletions in Plasmodium falciparum infections from Rukara, Rwanda’, Malaria Journal, 23(1), p. 150. doi:10.1186/s12936-024-04981-4.

IEEE

C. Schreidah et al., “Expansion of artemisinin partial resistance mutations and lack of histidine rich protein-2 and -3 deletions in Plasmodium falciparum infections from Rukara, Rwanda,” Malaria Journal, vol. 23, no. 1, p. 150, 2024, doi: 10.1186/s12936-024-04981-4.

BibTeX

@article{schreidah2024expansion,
  title     = {{Expansion of artemisinin partial resistance mutations and lack of histidine rich protein-2 and -3 deletions in Plasmodium falciparum infections from Rukara, Rwanda}},
  author    = {Schreidah, Cecile and Giesbrecht, David and Gashema, Pierre and Young, Neeva Wernsman and Munyaneza, Tharcisse and Muvunyi, Claude Mambo and Thwai, Kyaw L. and Mazarati, Jean-Baptiste and Bailey, Jeffrey A. and Juliano, Jonathan J. and Karema, Corine},
  journal   = {Malaria Journal},
  year      = {2024},
  volume    = {23},
  number    = {1},
  pages     = {150},
  doi       = {10.1186/s12936-024-04981-4},
  url       = {https://doi.org/10.1186/s12936-024-04981-4}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Citations by year

YearCitationsShare of the best year
202444
20251010
20261313

Its field-weighted citation impact is 7.29: it has been cited 7.29 times as often as the average work of the same field, type and year (1.00 is the world average).

Topic and keywords

Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Malaria Research and Control

  • Plasmodium falciparum
  • kelch13 mutations
  • multidrug resistance 1
  • lumefantrine resistance
  • dihydrofolate reductase
  • amodiaquine resistance
  • chloroquine resistance transporter
  • antimalarial drug resistance

Work with this paper

Most-cited papers in Medicine

All highly cited Medicine papers

Questions about this paper

How do I cite this paper in APA style?

Schreidah, C., Giesbrecht, D., Gashema, P., Young, N. W., Munyaneza, T., Muvunyi, C. M., Thwai, K. L., Mazarati, J.-B., Bailey, J. A., Juliano, J. J., & Karema, C. (2024). Expansion of artemisinin partial resistance mutations and lack of histidine rich protein-2 and -3 deletions in Plasmodium falciparum infections from Rukara, Rwanda. Malaria Journal, 23(1), 150. https://doi.org/10.1186/s12936-024-04981-4

How many times has this paper been cited?

27 times, according to OpenAlex on 19 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access at Malaria Journal: sign in and open the full text from this page.

Who wrote this paper?

Cecile Schreidah, David Giesbrecht, Pierre Gashema, Neeva Wernsman Young, Tharcisse Munyaneza, Claude Mambo Muvunyi, Kyaw L. Thwai, Jean-Baptiste Mazarati, Jeffrey A. Bailey, Jonathan J. Juliano, Corine Karema.

What is the DOI of this paper?

10.1186/s12936-024-04981-4, permanently at https://doi.org/10.1186/s12936-024-04981-4. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 19 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.